A forensic read on Solaredge Technologies, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Distress
Financial health
0.0
Distress distance
Clean
Earnings quality
5
Forensic signals
-74.7%
ROE
31.4%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Solaredge Technologies, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads -0.0, placing it in the Distress zone. 5 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-21.3%
FY2025
Return on invested capital.Return on invested capital is -21.3% in the latest fiscal year, against 0.8% in FY2023, having run between -57.8% and 0.8% across FY2023–FY2025 with no direction held. After-tax operating profit was $26M in FY2023 and ($238M) in FY2025, with operating income at 1.4% of revenue in FY2023, -189.5% in FY2024 and -25.5% in FY2025. The capital base behind it came down -67% across FY2023–FY2025, from $3.4B to $1.1B, so this return is struck on a smaller base than it started on. $196M of the $1.1B base at FY2025 is short-term investments (17.5%) — securities held beside cash, which the base keeps because only cash is subtracted from it; they earn the balance sheet's yield, which is not in the operating profit above, so the loss on the operating capital is larger than this rate shows.
stopped
FY2024→FY2025
Shareholder returns — halted.Capital returns have STOPPED — $50M of buybacks + dividends in FY2024, but ~$0 in FY2025. A halt usually means the company is conserving cash.
82d DSO
FY2024→FY2025
Receivables vs revenue.Days sales outstanding moved from 65 to 82 days FY2024→FY2025 (receivables +67% vs revenue +31%). Receivables are creeping up relative to sales. Across FY2023–FY2025 the day count ran 76 → 65 → 82 days, so the latest reading sits on top of a record that was flat or falling before it — one year's move, not a direction the business has been travelling in. Deferred revenue was roughly flat (-50%) over the same period, which doesn't corroborate a benign upfront-billing explanation for the receivables build. Both figures are measured on period-end balances rather than the beginning-plus-ending average, because averaging needs the balance a year before every reading — FY2024's opening balance is on file, but across the 3 fiscal years read here (FY2023–FY2025) the average yields only 2 day counts (1 step), too few to tell a climb from one year's move.DSO (days sales outstanding): the average days the company waits to collect cash after a sale.
221d
FY2024→FY2025
Inventory days.Days inventory outstanding moved from 214 to 221 FY2024→FY2025 (against cost of goods sold; inventory -14% vs -44% in cost of sales). Inventory did not fall as fast as cost of sales, so days on hand lengthened — watch for markdowns.
$2M
FY2024
Goodwill impairments.Took $2M of goodwill writedowns across 1 year (FY2024 ($2M)). Writedowns mean past acquisitions underperformed what was paid for them.
Key fundamentals
Latest Revenue$1.18B
Revenue Growth YoY+31.4%
Revenue CAGR (2yr)-36.9%
Net Margin-34.2%
Free Cash Flow$80.8M
Return on Equity-74.7%
Debt / Equity0.78x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Solaredge Technologies, Inc.'s actual 10-K/10-Q/8-K filings?